CommercialPrior AuthLow impact
Jynarque (tolvaptan)
Blue Cross & Blue Shield of Mississippi·MS · Nephrology·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their Jynarque (tolvaptan) policy with revised criteria for ADPKD treatment, including changes to age requirements and clinical improvement documentation for renewals. The policy clarifies that drug samples cannot count as stable therapy and removes previous quantity limit tables.
Action Required
Immediately: Billing team must ensure prior authorization is obtained for all Jynarque (tolvaptan) prescriptions using HCPCS J8499 for ADPKD patients. Verify prescriber is nephrologist or has nephrology consultation documented. Update encounter forms to remind providers that drug samples cannot be used to justify medical necessity. Claims will be denied without proper prior authorization.